Company profile
Synthesis Capital
Investment returns through relentless health impact
- Industry
- Venture Capital and Private Equity Principals
- Employees
- 7
- Headquarters
- Melbourne
- Founded
- 2023
- Office locations
- 1
Synthesis Capital company summary
Synthesis Capital is a company in the Venture Capital and Private Equity Principals industry, headquartered in Melbourne, founded in 2023. On LinkedIn the company has around 7 employees. Its listed specialties include Venture Capital Fund, Deep Technology, Medical Technology, Health Technology, Impact.
What technology does Synthesis Capital use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Synthesis Capital
Synthesis Capital targets investments in technologies and ventures that can change the face of global healthcare. Based in Australia and with a powerful pipeline across the Asia-Pacific region, Synthesis Capital invests in early-stage, deep technology medical, health and wellbeing-related ventures, from pre-seed to series A+. Structured as an Australian Early Stage Venture Capital Limited Partnership (ESVCLP) with a stapled managed investment trust, Synthesis Capital Fund I is built to optimise tax benefits for limited partners while maintaining investment flexibility. Synthesis Capital combines early-stage capital with market-leading venture development services – scaling its investment as risk is actively managed and addressed. Through powerful partnership with the MedTech Actuator – one of the Asia-Pacific’s leading medtech, healthtech and biotech venture development organisations – and its linkages across Singapore, India, South Korea and Japan, Synthesis Capital has direct access to a pipeline of investment-ready, high growth-potential enterprises, as well as the means to catalyse their development.
Specialties
Where is Synthesis Capital located?
Synthesis Capital lists 1 location.
Compare companies similar to Synthesis Capital
More companies in Venture Capital and Private Equity Principals.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Synthesis Capital synthesiscapital.vc | Venture Capital and Private Equity Principals | 7 | 2023 | Melbourne |
 Sequoia Capital sequoiacap.com | Venture Capital and Private Equity Principals | 347 | - | Menlo Park, CA |
 Andreessen Horowitz a16z.com | Venture Capital and Private Equity Principals | 1,030 | 2009 | Menlo Park, CA |
 Private Equity Insights pe-insights.com | Venture Capital and Private Equity Principals | 1,579 | 2013 | London, England |
 500 Global 500.co | Venture Capital and Private Equity Principals | 2,686 | 2010 | Palo Alto, California, US |
 Techstars techstars.com | Venture Capital and Private Equity Principals | 2,610 | 2006 | New York City, New York |
 Accel accel.com | Venture Capital and Private Equity Principals | 1,411 | - | Palo Alto, CA |
 Virgin virgin.com | Venture Capital and Private Equity Principals | 36,222 | - | London, England |
 Conscience VC conscience.vc | Venture Capital and Private Equity Principals | 2,001 | 2020 | Austin, TX |
 Peak XV Partners peakxv.com | Venture Capital and Private Equity Principals | 206 | - | Bangalore, Karnataka, IN |
 Greylock Partners greylock.com | Venture Capital and Private Equity Principals | 132 | - | Menlo Park, CA, US |
Frequently asked questions about Synthesis Capital
What does Synthesis Capital do?
Synthesis Capital targets investments in technologies and ventures that can change the face of global healthcare. Based in Australia and with a powerful pipeline across the Asia-Pacific region, Synthesis Capital invests in early-stage, deep technology medical, health and wellbeing-related ventures, from pre-seed to series A+. Structured as an Australian Early Stage Venture Capital Limited Partnership (ESVCLP) with a stapled managed investment trust, Synthesis Capital Fund I is built to optimise tax benefits for limited partners while maintaining investment flexibility. Synthesis Capital combines early-stage capital with market-leading venture development services – scaling its investment as risk is actively managed and addressed. Through powerful partnership with the MedTech Actuator – one of the Asia-Pacific’s leading medtech, healthtech and biotech venture development organisations – and its linkages across Singapore, India, South Korea and Japan, Synthesis Capital has direct access to a pipeline of investment-ready, high growth-potential enterprises, as well as the means to catalyse their development.
How many employees does Synthesis Capital have?
Synthesis Capital has around 7 employees on LinkedIn.
Where is Synthesis Capital headquartered?
Synthesis Capital is headquartered in Melbourne.
When was Synthesis Capital founded?
Synthesis Capital was founded in 2023.
Build a lead list from companies like Synthesis Capital
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.